Now showing items 1-2 of 2

    • DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT 

      Jones, Rob; Sheehan, Bart; Phillips, Patrick; Juszczak, Ed; Adams, Jessica; Baldwin, Ashley; Ballard, Clive et al. (2009-07-24)
      Abstract Background Alzheimer's disease (AD) is the commonest cause of dementia. Cholinesterase inhibitors, such as donepezil, are the drug class with the best evidence of efficacy, licensed for mild to moderate AD, while ...
    • Neural correlates of attention-executive dysfunction in Lewy body dementia and Alzheimer’s disease 

      Firbank, Michael; Kobeleva, Xenia; Cherry, George; Killen, Alison; Gallagher, Peter; Burn, David J.; Thomas, Alan et al. (Wiley, 2015-12-26)
      Attentional and executive dysfunction contribute to cognitive impairment in both Lewy body dementia and Alzheimer’s disease. Using functional MRI, we examined the neural correlates of three components of attention (alerting, ...